Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Pharmaceutical Sterility Testing Market

Pharmaceutical Sterility Testing Market Trends

Report ID: GMI9112
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Pharmaceutical Sterility Testing Market Trends

The rising prevalence of infectious diseases worldwide is a significant driver fueling the growth of the market, by increasing the demand for safe and sterile pharmaceutical products, such as vaccines and other sterile medications.
The accelerated development of vaccines and therapies to combat infectious diseases, further contributes to this demand.
Sterility testing plays a crucial role in ensuring the safety and efficacy of pharmaceutical products by detecting and preventing the presence of harmful microorganisms.
Thus, with the increasing demand for sterile pharmaceuticals to combat infectious diseases, the market is expected to experience robust growth in the coming years.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Pharmaceutical sterility testing market size was USD 741.3 million in 2023 and is expected to register 10.8% CAGR from 2024-2032 owing to the increased demand for sterile products and biologics, such as vaccines and gene therapies worldwide.

The kits & reagents segment recorded 52.1% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its ability to provide comprehensive and convenient solutions.

North America pharmaceutical sterility testing industry reached USD 317.3 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to a strong pharmaceutical industry and stringent regulatory environment in the region.

Charles River Laboratories, Nelson Laboratories, LLC, Merck KGaA, Pacific BioLabs Inc., Rapid Micro Biosystems Inc., SGS Société Générale de Surveillance SA., STERIS Corporation, and Thermo Fisher Scientific Inc., are some of the major pharmaceutical sterility testing companies worldwide.